These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 19092117

  • 1. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM, Ruggenenti P, Remuzzi G, Consensus Study Group.
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recurrence of hemolytic uremic syndrome after renal transplantation.
    Seitz B, Albano L, Vocila F, Mzoughi S, Aoudia R, Guitard J, Ribes D, Vachet-Copponat H, Mourad G, Bienaimé F, Dahan P, Frémeaux-Bacchi V, Cassuto E.
    Transplant Proc; 2007 Oct; 39(8):2583-5. PubMed ID: 17954182
    [Abstract] [Full Text] [Related]

  • 5. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology.
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [Abstract] [Full Text] [Related]

  • 6. Hemolytic uremic syndrome recurrence after renal transplantation.
    Loirat C, Fremeaux-Bacchi V.
    Pediatr Transplant; 2008 Sep; 12(6):619-29. PubMed ID: 18482212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.
    Riedl M, Rosales A, Zimmerhackl LB, Jungraithmayr T.
    Pediatr Transplant; 2011 May; 15(3):225-8. PubMed ID: 21492349
    [No Abstract] [Full Text] [Related]

  • 9. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.
    Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G, International Registry of Recurrent and Familial HUS/TTP.
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Membrane cofactor protein and factor I: mutations and transplantation.
    Kavanagh D, Goodship TH.
    Semin Thromb Hemost; 2006 Mar; 32(2):155-9. PubMed ID: 16575690
    [Abstract] [Full Text] [Related]

  • 14. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 15. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [Abstract] [Full Text] [Related]

  • 16. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship TH, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodríguez de Córdoba S, Sánchez-Corral P, Skerka C, Zipfel PF, Perkins SJ.
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [Abstract] [Full Text] [Related]

  • 17. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E, Alberti M, Noris M.
    J Nephrol; 2012 Mar; 25(6):911-7. PubMed ID: 22760880
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T.
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [Abstract] [Full Text] [Related]

  • 19. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF, Skerka C.
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [Abstract] [Full Text] [Related]

  • 20. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
    Józsi M, Heinen S, Hartmann A, Ostrowicz CW, Hälbich S, Richter H, Kunert A, Licht C, Saunders RE, Perkins SJ, Zipfel PF, Skerka C.
    J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.